Diagnostics

Advocates and doctors urge lowering the colorectal cancer screening age to 45 as rates soar in young adults, sparking a debate on policy and resources.

Italian med-tech firm Esaote unveils its AI-driven Prostate Attention Map, promising a new era of accuracy and confidence in prostate cancer detection.

A European firm is bringing passive brain-computer interface tech to the US, promising safer AI but raising profound questions about mental privacy.

A new partnership combines advanced AI with human expertise to bring hope and clarity to 300 million people on a long, isolating journey to diagnosis.

The precision oncology firm reports a dramatic cut in net loss and a strategic pivot paying off, bolstered by a new U.S. patent for its cancer tech.

Genomic Testing Cooperative opens a Houston lab, leveraging the city's elite oncology ecosystem to expand its unique cooperative model for cancer testing.

A novel compound, IRX4204, shows promise in preventing triple-negative breast cancer in lab studies, offering new hope for a safe, effective preventative.

As AI progress stalls on bad data, a new research lab is bringing scientific discipline to the industry's most overlooked and critical pillar.

The creator of virtual visual field testing becomes Carrot, launching a full diagnostics platform to challenge industry giants with a focus on efficiency.

A landmark study reveals a new test can predict and help prevent premature births in low-risk pregnancies, with a Texas hospital playing a leading role.

With a new MD and 270+ stores in five years, Specsavers is intensifying its push to reshape Canada's eyecare landscape. What's next for the disruptor?

In the wake of global infant formula recalls, a new diagnostic tool offers rapid detection of the dangerous cereulide toxin to protect vulnerable patients.

Advocates call for colorectal cancer screening to start at 45 as cases surge in people under 50, raising questions about Canada's readiness.

Microsoft partners with Neuro-AI pioneer HABS to create AI that understands human cognition, ushering in an era of unprecedented innovation and ethical debate.

As evidence for psychedelic therapy mounts, a key advocacy group brings its case to the UN, challenging decades of prohibitive international drug policy.

Eight innovators receive a major prize to pursue high-risk, radical ideas in the fight against Alzheimer’s, aiming to change the paradigm of neuroscience.

By adding powerful new technologies to its genome sequencing, Baylor Genetics aims to solve medical mysteries and end the diagnostic odyssey for patients.

A new partnership between two Chinese biotech leaders aims to create an industrial-scale gene factory, accelerating breakthroughs in medicine and agriculture.

A new Edmonton health centre embeds pharmacy services directly into patient care, aiming to fix a fragmented system and empower local pharmacists.

Vitestro raises $70M from Labcorp and Mayo Clinic to deploy its AI-powered blood-drawing robot, addressing global phlebotomist shortages and care quality.